Nivolumab During Active Surveillance After Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 Study
Clinical trial NCT05491616 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05491616
- Sponsor
- Erasmus Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-29
- Primary completion
- 2026-10-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.